Kyowa Hakko Kogyo Aktie
14,90EUR | -0,20EUR | -1,32% |
WKN: 858523 / ISIN: JP3256000005
Aktionärsstruktur
Inhaber | in % |
---|---|
Kirin Holdings Co., Ltd. | 54,95 |
Freefloat | 43,83 |
Nomura Asset NEXT FUNDS NIKKEI 225 ETF (1321) | 1,68 |
Nomura Asset NEXT FUNDS TOPIX ETF (1306) | 1,31 |
Nikko Exchange Traded Index Fund 225 | 0,82 |
Government Pension Fund - Global (The) | 0,76 |
Daiwa Asset iFreeETF NIKKEI 225 (Yearly Dividend Type) (1320) | 0,76 |
Dai-ichi Life Holdings, Inc. | 0,56 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 5 267 | 7 242 | 5 752 | 5 982 | 5 974 |
Umsatz pro Mitarbeiter in Mio. EUR | 58,06 | 43,96 | 61,24 | 66,59 | 74,03 |
Bilanz (in Mio. JPY) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 448 610 | 442 482 | 518 231 | 542 189 | 611 124 |
Summe Anlagevermögen | 335 843 | 358 808 | 403 641 | 397 692 | 414 818 |
Summe Aktiva | 784 453 | 801 290 | 921 872 | 939 881 | 1 025 942 |
Bilanz (in Mio. JPY) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 106 203 | 102 893 | 184 710 | 177 055 | 189 523 |
Summe Eigenkapital | 678 250 | 698 396 | 737 162 | 762 826 | 836 418 |
Summe Passiva | 784 453 | 801 289 | 921 872 | 939 881 | 1 025 941 |
Adresse
Otemachi Financial City Grand Cube, 100-0004 Tokyo | |
Telefon | +81 (3) 5205-7200 |
Fax | +81 (3) 5205-7182 |
Internet | https://www.kyowakirin.co.jp/index.html |
Management
Abdul Mullick
Chief International Business Officer |
Akira Morita
Independent Outside Director |
Hiroshi Komatsu
Auditor |
Hiroshi Sonegawa
Managing Executive Officer & GM-Sales |
Jun Arai
Independent Outside Director |
Kazuki Nemoto
Manager-Legal Affairs |
Keiji Kuwata
Auditor |
Kenji Shibata
Executive Officer & Manager-Corporate Audit |
Masashi Miyamoto
President, CEO & Representative Director |
Motohiko Kawaguchi
Managing Executive Officer |
Rumiko Nakata
Independent Outside Director |
Shinjiro Akieda
Director |
Takashi Oyamada
Independent Outside Director |
Takeshi Matsushita
Executive Officer & Manager-Medical Affairs |
Takeshi Minakata
Director |
Takeyoshi Yamashita
Director & Chief Medical Officer |
Takuo Hirose
GM-Global Information & Communication Technology |
Toshifumi Mikayama
Director & Vice President |
Toshiro Suda
Manager-Corporate Strategy |
Wataru Murata
Senior Managing Executive Officer |
Wayne Bowler
Group Head-Business Development |
Yasuo Fujii
Chief Strategy Officer |
Yoshifumi Torii
Executive Officer & General Manager-Research |
Yoshihisa Suzuki
Independent Outside Director |
Yuko Haga
Independent Outside Director |
Yutaka Osawa
Representative Director & Chief Compliance Officer |